4E-BP1 deficiency is a characteristic of pancreatic ductal adenocarcinomas (PDACs) (15), as confirmed by our proteomic analysis of primary and metastatic tumors (Figure 1B) and by immunoblot analysis of PDAC cell lines (Figure 1C). This evidence concerns the gene EIF4EBP1 and metastatic neoplasm.